W Bodmer1. Show Affiliations » 1. Imperial Cancer Research Fund, London, U.K.
Abstract
Entities: Disease
Mesh: See more » AnimalsAntigens, Neoplasm/analysisHistocompatibility Antigens Class I/analysisHumansImmunotherapy/methodsMiceNeoplasms/immunologyNeoplasms/therapyT-Lymphocytes/immunology
Substances: See more » Antigens, NeoplasmHistocompatibility Antigens Class I
Year: 1992 PMID: 1389499 DOI: 10.1016/0959-8049(92)90086-h
Source DB: PubMed Journal: Eur J Cancer ISSN: 0959-8049 Impact factor: 9.162